Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
US-based Vertex Pharmaceuticals has agreed to acquire a potential treatment for cystic fibrosis from Concert Pharmaceuticals, also in the US, for $160 million.   9 March 2017
Asia
Bayer has been defeated in a patent battle against India-based drugs companies Alembic Pharmaceuticals and Natco Pharma today.   8 March 2017
Americas
US-based biopharmaceutical company Arena Pharmaceuticals and Eisai, a drugs company based in Japan, have filed a complaint against Teva for patent infringement over a weight-loss generic drug.   8 March 2017
Americas
Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.   7 March 2017
Americas
The Patent Trial and Appeal Board has rejected Celltrion’s challenge against a Genentech patent centring on a method of treating rheumatoid arthritis, stating that the challenged patent did not show any reasonable likelihood of being invalid.   7 March 2017
Americas
Law firm Cooley has hired Ryan Sansom as a partner to enhance its life sciences practice in Boston.   6 March 2017
Biotechnology
The English High Court has ruled in favour of Fujifilm Kyowa Kirin Biologics in a case against AbbVie, granting Fujifilm an Arrow declaration allowing it to market a biosimilar of AbbVie’s Humira (adalimumab), a medication used to treat arthritis.   6 March 2017
Europe
The English High Court handed down a split decision on patentability in a dispute between Edwards Lifesciences and Boston Scientific over patents covering transcatheter heart valves.   6 March 2017
Americas
Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.   3 March 2017
Americas
Otsuka Pharmaceutical has agreed to acquire Neurovance, a privately held clinical stage pharma company.   3 March 2017